Literature DB >> 25628950

A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.

Dan Qiao1, Zhiyu Wang1, Yaohong Lu2, Xiaoting Wen1, Hongtao Li1, Hui Zhao1.   

Abstract

Lung cancer (LCa) is one of the most common and deadly malignancies in elderly patients. During the course of the disease, these patients frequently present with lower respiratory tract infection. Therefore, this study aims to investigate the clinical features of lower respiratory tract infection in elderly LCa patients and evaluate the impact on overall survival rate. Clinical and laboratory data were analyzed retrospectively for a total of 1936 patients that were over 60-years-old. Patients were classified into three groups based on pulmonary diseases: Group 1, lung cancer (LCa); Group 2, chronic obstructive pulmonary disease (COPD); and Group 3, other medical diseases without pulmonary problems (OMD). Univariate and multivariate analysis were used to evaluate related risk factors of infections and prognostic factors. The infection rate of the LCa group (46.25%) was significantly higher than the COPD (31.40%) and OMD (23.33%) groups. Polymicrobial infections were most prevalent in the LCa group (28.75%), which far exceeded the prevalence in COPD (11.05%) and OMD (4.44%) groups. In LCa patients, the most frequent pathogens were Gram-negative bacteria (44.87%), followed by fungi (34.62%) and Gram-positive bacteria (20.51%), the major pattern of polymicrobial infections was mixed Gram-negative bacteria and fungi (43.48%). Multivariate analysis revealed that COPD, pleural effusion, anatomical type, low cellular immune function, and length of hospital stay were related risk factors of lower respiratory tract infection in elderly LCa patients. A multivariate Cox proportional hazards regression model revealed that age, stage of TNM, surgical resection, antitumor therapy, lower respiratory tract infection, COPD, and pleural effusion were independent prognostic factors for cancer-related death. Patients who received effective antimicrobial treatment had a better outcome than those who did not respond to antimicrobial drugs (HR = 0.458, P < 0.05). Understanding lower respiratory tract infection in elderly LCa patients is vital if we are to set up corresponding measures and to target effective antimicrobial treatment.

Entities:  

Keywords:  Lung cancer; infection; prognosis; risk factors

Year:  2014        PMID: 25628950      PMCID: PMC4300720     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  37 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

Review 2.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

3.  Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.

Authors:  Anat Gafter-Gvili; Abigail Fraser; Mical Paul; Leonard Leibovici
Journal:  Ann Intern Med       Date:  2005-06-21       Impact factor: 25.391

4.  Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer.

Authors:  J A Langendijk; N K Aaronson; J M de Jong; G P ten Velde; M J Muller; R J Lamers; B J Slotman; E F Wouters
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

5.  Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

Authors:  K S Albain; J J Crowley; M LeBlanc; R B Livingston
Journal:  J Clin Oncol       Date:  1990-09       Impact factor: 44.544

6.  Pulmonary resection for malignancy in the elderly: is age still a risk factor?

Authors:  S Pagni; A McKelvey; C Riordan; J A Federico; R B Ponn
Journal:  Eur J Cardiothorac Surg       Date:  1998-07       Impact factor: 4.191

Review 7.  Infection in cancer patients. A continuing association.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

8.  Pulmonary infections in lung cancer patients at diagnosis.

Authors:  S Putinati; L Trevisani; M Gualandi; G Guerra; M R Rossi; S Sartori; A Potena
Journal:  Lung Cancer       Date:  1994-09       Impact factor: 5.705

9.  [Respiratory infection and bronchial cancer].

Authors:  C Brambilla; P Romand; C Vanderkerckhove; D Moro
Journal:  Rev Mal Respir       Date:  1992       Impact factor: 0.622

10.  Fatigue in advanced cancer: a prospective controlled cross-sectional study.

Authors:  P Stone; J Hardy; K Broadley; A J Tookman; A Kurowska; R A'Hern
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  11 in total

1.  Commensal Microbiota Promote Lung Cancer Development via γδ T Cells.

Authors:  Chengcheng Jin; Georgia K Lagoudas; Chen Zhao; Susan Bullman; Arjun Bhutkar; Bo Hu; Samuel Ameh; Demi Sandel; Xu Sue Liang; Sarah Mazzilli; Mark T Whary; Matthew Meyerson; Ronald Germain; Paul C Blainey; James G Fox; Tyler Jacks
Journal:  Cell       Date:  2019-01-31       Impact factor: 41.582

2.  Video-assisted thoracoscopic surgery for non-small-cell lung cancer in elderly patients: a single-center, case-matched study.

Authors:  Keqiang Liu; Jing Zhao; Weiqiang Zhang; Jian Tan; Jingbo Ma; Yingxin Pei
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patients.

Authors:  Maosong Ye; Xia Gu; Yang Han; Meiling Jin; Tao Ren
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

4.  Health Resource Utilization in Patients with Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy in China.

Authors:  Jing Shi; Jun Zhu
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

5.  Video-assisted thoracoscopic surgery for non-small-cell lung cancer is beneficial to elderly patients.

Authors:  Yan Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  The role of bacterial culture by bronchoscopy in patients with lung cancer: a prospective study.

Authors:  Matthew Koslow; Gali Epstein Shochet; Alona Matveychuk; Lilach Israeli-Shani; Alexander Guber; David Shitrit
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

7.  Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at time of diagnosis.

Authors:  Attila Nagy; Veronika Müller; Abigel M Kolonics-Farkas; Noemi Eszes; Krisztina Vincze; Gabor Horvath
Journal:  Thorac Cancer       Date:  2019-07-17       Impact factor: 3.500

Review 8.  Host-Microbiome Interaction in Lung Cancer.

Authors:  Qiang Dong; Eric S Chen; Chen Zhao; Chengcheng Jin
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

9.  Prognostic Significance of TLR2, SMAD3 and Localization-dependent SATB1 in Stage I and II Non-Small-Cell Lung Cancer Patients.

Authors:  Justyna Durślewicz; Anna Klimaszewska-Wiśniewska; Jakub Jóźwicki; Paulina Antosik; Marta Smolińska-Świtała; Maciej Gagat; Adam Kowalewski; Dariusz Grzanka
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 10.  Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer.

Authors:  Dan Ai; Yan Guan; Xiu-Ju Liu; Chu-Feng Zhang; Peng Wang; Hong-Lu Liang; Qi-Sen Guo
Journal:  Onco Targets Ther       Date:  2016-09-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.